世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5351
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・脊髄性筋萎縮症（SMA）治療の市場動向
・企業の競争状況、市場シェア
・脊髄性筋萎縮症（SMA）治療の種類別市場規模と予測2016-2027（ヌシネルセン、オナセムノゲンアベパルボベック）
・脊髄性筋萎縮症（SMA）治療の用途別市場規模と予測2016-2027（タイプ1SMA、タイプ2 SMA、その他）
・脊髄性筋萎縮症（SMA）治療の北米市場規模2016-2027（アメリカ、カナダ）
・脊髄性筋萎縮症（SMA）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・脊髄性筋萎縮症（SMA）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・脊髄性筋萎縮症（SMA）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・脊髄性筋萎縮症（SMA）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Biogen、Novartis、Roche、Astellas Pharma、Genzyme Corporation）
・結論

Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma

Market Analysis and Insights: Global Spinal Muscular Atrophy (SMA) Therapeutic Market
The global Spinal Muscular Atrophy (SMA) Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal Muscular Atrophy (SMA) Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal Muscular Atrophy (SMA) Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal Muscular Atrophy (SMA) Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal Muscular Atrophy (SMA) Therapeutic market.

Global Spinal Muscular Atrophy (SMA) Therapeutic Scope and Market Size
Spinal Muscular Atrophy (SMA) Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy (SMA) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nusinersen
Onasemnogen Abeparvovec

Segment by Application
Type 1 SMA
Type 2 SMA
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen
Novartis
Roche
Astellas Pharma
Genzyme Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nusinersen
1.2.3 Onasemnogen Abeparvovec
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 1 SMA
1.3.3 Type 2 SMA
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Perspective (2016-2027)
2.2 Spinal Muscular Atrophy (SMA) Therapeutic Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Spinal Muscular Atrophy (SMA) Therapeutic Industry Dynamic
2.3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Trends
2.3.2 Spinal Muscular Atrophy (SMA) Therapeutic Market Drivers
2.3.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
2.3.4 Spinal Muscular Atrophy (SMA) Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Therapeutic Revenue
3.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2020
3.5 Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy (SMA) Therapeutic Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy (SMA) Therapeutic Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Type (2022-2027)

5 Spinal Muscular Atrophy (SMA) Therapeutic Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
6.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
6.2.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
6.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
6.3.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
6.4 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
6.4.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
7.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
7.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
7.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
9.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Introduction
11.1.4 Biogen Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Introduction
11.2.4 Novartis Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Introduction
11.3.4 Roche Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Introduction
11.4.4 Astellas Pharma Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Details
11.5.2 Genzyme Corporation Business Overview
11.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Introduction
11.5.4 Genzyme Corporation Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
11.5.5 Genzyme Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nusinersen
Table 3. Key Players of Onasemnogen Abeparvovec
Table 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2022-2027)
Table 10. Spinal Muscular Atrophy (SMA) Therapeutic Market Trends
Table 11. Spinal Muscular Atrophy (SMA) Therapeutic Market Drivers
Table 12. Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
Table 13. Spinal Muscular Atrophy (SMA) Therapeutic Market Restraints
Table 14. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2020)
Table 17. Ranking of Global Top Spinal Muscular Atrophy (SMA) Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy (SMA) Therapeutic Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy (SMA) Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biogen Company Details
Table 62. Biogen Business Overview
Table 63. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product
Table 64. Biogen Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
Table 65. Biogen Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product
Table 69. Novartis Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product
Table 74. Roche Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Astellas Pharma Company Details
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product
Table 79. Astellas Pharma Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Astellas Pharma Recent Development
Table 81. Genzyme Corporation Company Details
Table 82. Genzyme Corporation Business Overview
Table 83. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product
Table 84. Genzyme Corporation Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
Table 85. Genzyme Corporation Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Nusinersen Features
Figure 3. Onasemnogen Abeparvovec Features
Figure 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Type 1 SMA Case Studies
Figure 6. Type 2 SMA Case Studies
Figure 7. Other Case Studies
Figure 8. Spinal Muscular Atrophy (SMA) Therapeutic Report Years Considered
Figure 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Players in 2020
Figure 14. Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2020
Figure 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Region (2016-2027)
Figure 38. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Biogen Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
Figure 61. Genzyme Corporation Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の脊髄性筋萎縮症遺伝子検出市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy Genetic Detection Market Size, Status and Forecast 2021-2027
QFJ1-4895 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）、用途別市場規模（病院、クリニック、診断センター）...

世界の球脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6018 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、球脊髄性筋萎縮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト）、用途別市場規模（病院、整形外科クリニック、外来手術センター）、主要...

世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年）

Global Multiple System Atrophy Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4535 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、多系統萎縮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）、用途別市場規模（病院、クリニ...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の非アルコール性脂肪性肝炎（NASH）治療市場規模・現状・予測（2021年-2027年）

Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4586 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非アルコール性脂肪性肝炎（NASH）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（保険適用外、治療）、用途別市場規模（病院薬局、オンラインプロバイダー、小売薬局）、主要地域別市場規模（北米、アメ...

世界の脊髄刺激療法市場規模・現状・予測（2021年-2027年）

Global Spinal Cord Stimulation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5349 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄刺激療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（充電式、非充電式）、用途別市場規模（病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5837 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、リンパ芽球性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞移植、標的療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のマゴットセラピー市場規模・現状・予測（2021年-2027年）

Global Maggot Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4454 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、マゴットセラピーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬品、薬用包帯、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の脊椎インプラント＆手術装置市場規模・現状・予測（2021年-2027年）

Global Spinal Implants and Surgery Devices Market Size, Status and Forecast 2021-2027
QFJ1-5350 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脊椎インプラント＆手術装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（脊椎固定術、運動保存/非固定術、脊椎圧迫骨折治療、脊椎減圧術）、用途別市場規模（開腹手術、低侵襲手術）、主要地域別市場規模（北...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年） Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior horn of the spinal cord leads to muscle weakness and muscular atrophy.The Spinal muscular atrophy drugs Can effectively alleviate the symptoms of the …
世界の脊髄性筋萎縮症遺伝子検出市場規模・現状・予測（2021年-2027年） A detection method for Spinal Muscular Atrophy Market Analysis and Insights: Global Spinal Muscular Atrophy Genetic Detection Market The global Spinal Muscular Atrophy Genetic Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
世界の球脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年） SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially the weakness of the two lower limbs to walk, tongue muscle atrophy is usually one of the main symptoms. Market Analysis and Insights: Global Spinal and …
世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Duchenne Muscular Dystrophy (DMD) Market The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …